Altimmune Inc (ALT)
5.32
-0.25
(-4.49%)
USD |
NASDAQ |
Mar 28, 16:00
5.33
+0.01
(+0.19%)
After-Hours: 20:00
Altimmune Market Cap: 409.71M for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Viking Therapeutics Inc | 2.879B |
Eli Lilly and Co | 738.75B |
Amgen Inc | 164.90B |
Terns Pharmaceuticals Inc | 254.91M |
Pfizer Inc | 142.87B |
Market Cap Related Metrics
PS Ratio | 18888.85 |
Price to Book Value | 3.317 |
Price | 5.32 |
Earnings Yield | -25.19% |